This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Compact view
Research pass: stub-manual Compound OTHER LOW

Phenytoin

Extended Research
Extended Research

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

Editor's verdict OTHER LOW

"MANUAL-STUB. First-line anticonvulsant in clinical use since 1938. Jack Dreyfus championed it as a cognitive / mood agent in the 1970s, funding the Dreyfus Medical Foundation's nootropic-leaning research program. Modern lit acknowledges some cognitive benefits in epilepsy populations but the off-label nootropic use is heavily constrained by therapeutic window (10-20 µg/mL serum), gingival hyperplasia, hirsutism, ataxia, and SJS risk. Verdict likely SKIP for nootropic use due to safety profile + non-linear PK. Stays Rx-prescribed for its primary indication."

Research pass: stub-manual

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…